Table 2 Comparison of baseline characteristics between the patient groups
Variables | Non-early bleeding (N = 266) | Early bleeding (N = 19) | P value |
|---|---|---|---|
Age | 60.65 ± 10.695 | 58.89 ± 11.396 | 0.492 |
Gender (Male) | 217 (81.6%) | 15 (78.9%) | 0.776 |
Etiology (HBV/HCV/Alcohol/Others) | 109(41.1%)/30(11.3%) /99(37.2%)/28(10.5%) | 6(31.6%)/2(10.5%) /7(36.8%)/4(21.1%) | 0.563 |
Previous history of variceal bleeding | 30 (11.3%) | 3 (15.8%) | 0.553 |
Indication of EVL | 0.835 | ||
prophylactic | 47 (17.7%) | 3 (15.8%) | |
emergency | 219 (82.3%) | 16 (84.2%) | |
Presence of PVT | 24 (9.0%) | 2 (10.5%) | 0.943 |
Presence of HCC | 114 (42.9%) | 8 (42.1%) | 0.962 |
Child-Pugh score | 0.313 | ||
A | 84 (31.6%) | 5 (26.3%) | |
B | 136 (51.1%) | 8 (42.1%) | |
C | 46 (17.3%) | 6 (31.6%) | |
Presence of Ascites | 156 (58.6%) | 14 (73.7%) | 0.197 |
Presence of Hepatic encephalopathy | 50 (18.8%) | 5 (26.3%) | 0.703 |
Hemoglobin, g/dL | 9.25 ± 2.107 | 9.21 ± 1.913 | 0.935 |
Platelet, x106/L | 94936.09 ± 53070.05 | 87315.79 ± 51012.04 | 0.545 |
Prothrombin time, sec | 16.20 ± 3.11 | 17.26 ± 3.20 | 0.157 |
Total bilirubin, mg/dL | 2.97 ± 4.20 | 5.17 ± 9.36 | 0.050 |
Albumin, g/dL | 3.08± 0.53 | 3.02 ± 0.54 | 0.629 |
Na, mmol/L | 135.93 ± 5.14 | 135.63 ± 5.23 | 0.808 |
Child Pugh score | 7.74 ± 2.02 | 8.52 ± 2.71 | 0.233 |
MELD | 13.63 ± 5.55 | 15.26 ± 6.57 | 0.223 |
6weeks bleeding-related mortality | 27(10.2%) | 6(31.6%) | 0.014 |